Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis
Triin Umbleja(Harvard University), Steven Grinspoon(Massachusetts General Hospital), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Jack T. Stapleton(University of Iowa), Craig A. Sponseller, Marshall J. Glesby, Kim-Lien Nguyen(VA Greater Los Angeles Healthcare System), M. Urooj Zafar(Icahn School of Medicine at Mount Sinai), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Win Min Han(HIV Netherlands Australia Thailand Research Collaboration), Marissa R Diggs(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Arijeet K. Gattu(Harvard University), Alex B Lu(Cancer Research And Biostatistics), Rachel A Bender Ignacio(Infectious Disease Research Institute), Gerald S Bloomfield(Clinical Research Institute), Judith S Currier(University of California, Los Angeles), Markella V. Zanni(Harvard University), Pamela S Douglas(Duke University), Michael J. Frank(Medical College of Wisconsin)
Cited by 2
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k